Supernus Pharmaceuticals | SUPN - Işletme Karı





Işletme Karı Değişiklik Tarih
Abbott USD 1.36B 775M 2026-09
ANI Pharmaceuticals USD 51.84M 12M 2026-09
Aurora Cannabis CAD -8.73M 1.3M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Canopy Growth CAD -17.58M 9.9M 2026-06
Cara Therapeutics USD -7.05M 1.11M 2026-03
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Eisai JPY 16.7B 8.03B 2026-09
Eli Lilly USD 12.46B 2.68B 2026-06
Novo Nordisk DKK 33.76B 25.86B 2026-06
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 3.7M 2026-09
Pfizer USD 662M 5M 2026-09
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
United Therapeutics USD 241.3M 89.5M 2026-09
Xeris Pharmaceuticals USD 5.17M 2.74M 2026-06